Results for tag: "Ampyra"

Ampyra (dalfampridine) is a central nervous system drug used to improve walking in adults with multiple sclerosis (MS). It is the first and only FDA-approved medication to improve walking in people with MS. Ampyra works by blocking the potassium channels in nerve cells, which helps to improve the conduction of nerve signals. This can help to improve walking speed and reduce fatigue in people with MS. Ampyra is available in tablet form and is taken twice daily. It is typically used in combination with other MS treatments, such as physical therapy and medications. Common side effects of Ampyra include dizziness, headache, and nausea. The Ampyra market is composed of pharmaceutical companies that manufacture and market the drug. These companies include Acorda Therapeutics, Biogen, and EMD Serono. Additionally, there are several generic versions of Ampyra available in the market. Show Less Read more